Background: Gastric adenocarcinoma is known to be a markedly invasive disease with high potential for metastasis. Hepatocyte growth factor (HGF)/HGF receptor (MET) signaling pathway activation is an assumed mechanism of malignant transformation and metastatic potential of tumors. Metastasis associated with colon cancer-1 (MACC-1) has been identified as a key regulator of HGF/MET signaling. However, its role in gastric cancer is not well understood. Aim of this study is to assess the expression of MACC-1 in gastric cancer, its relation to other clinical and pathologic parameters and its impact on progression free and overall survival. Patient and Methods: Evaluation of MACC-1 protein expression by immune-histochemistry was done on paraffin-embedded tissues obtained from 46 patients with gastric cancer, where samples were taken from the tumor and adjacent normal mucosa. Results: MACC-1 was predominantly localized in the cytoplasm or membrane of the primary cancer cells. High MACC-1 expression was found in 63.1% (29/46) of tumor samples, while MACC-1 expression was not detected in normal mucosa (P < 0.01). Expression of MACC-1 was significantly associated with older age, larger tumor size, deeper tumor invasion, presence of lymph node metastasis, distant metastasis and advanced clinical stage (p < 0.05), while no relation was found with gender, tumor location or histologic classification (p > 0.05). Progression free and overall survival were significantly higher in patients with low MACC-1 expression compared to patients with high expression (Log Rank test, p = 0.02 and 0.04, consequently). Conclusion: Our study found that MACC-1 expression is strongly related to gastric cancer stage and both progression free and overall survival, suggesting that MACC-1 promotes tumorigenesis and its expression may be used as signal of bad prognosis in gastric cancer.
Introduction
Gastric cancer is a highly lethal disease due to marked invasion and metastasis [1] [2] . The mechanism of tumor invasion and metastasis includes cell movement, adhesion, extracellular matrix degradation and angiogenesis [3] [4] . Biological markers associated with invasion and metastasis such as aberrant activation of the hepatocyte growth factor (HGF)/HGF receptor (MET) signaling pathway has been a focus for gastric cancer research [3] [5] . Distant organ metastasis is a signal of poor prognosis in patients with gastric cancer. Liver is a common target organ of gastric cancer metastasis [6] . Hepatic stellate cells (HSCs) are a type of liver-specific mesenchymal cells which are considered a main component of the prometastatic liver microenvironment. These cells can be activated by tumor-derived factors to stimulate the metastatic growth of tumor cells [7] .
Metastasis-associated with colon cancer-1 (MACC-1) is a member of a family of soluble proteins. MACC1 hastens migration, invasion and metastasis of cancer cells through activating the hepatocyte growth factor (HGF)/MET proto-oncogene (c-Met) signaling pathway [8] , together with provoking multiple cellular responses regulating cell morphogenesis, migration and breakdown of the extracellular matrix [9] . A study has previously demonstrated that the expression MACC1 is significantly higher in activated HSCs. MACC1 is reported to be associated with distant metastasis in gastric cancer [10] . Overexpression of MACC1 increases invasion in cancer cells by enhancing epithelial-mesenchymal transition (EMT) [11] , and is significantly correlated to decreased overall survival (OS) and disease-free survival (DFS) [12] .
MACC-1 was first identified during a genome wide search for genes differentially expressed in colorectal cancer [13] . However, the significance of MACC-1 expression and its impact on prognosis in gastric adenocarcinoma are still controversial.
Materials and Methods
This study includes 46 gastric cancer patients who were diagnosed at Zagazig University Hospital in the period between February 2015 and January 2018. All patients with newly diagnosed gastric cancer during that time period were enrolled in the study provided they had normal cardiac, renal and hepatic functions and an ECOG performance status of ≤2. Samples were taken with endoscopic biopsy from the gastric cancer tissue and adjacent normal gastric tissue more than 5 cms from the margin. Samples were sent to the histopathology laboratory where they were formalin fixed and paraffin-embedded for histopathologic and immunohistochemical analysis. All patients were subjected to the fol- 
Immunohistochemistry
Immunohistochemical analysis was performed to study altered protein expression in 46 human gastric cancer and adjacent normal tissue samples, as previously described [14] [15]. Paraffin-embedded formalin-fixed tissue slides (4 μm) were baked at 60˚C for 2 h, followed by deparaffinization with xylene, and 
Statistical Analysis
Statistical analyses were performed using SPSS24.0 software. Measurement data were analyzed using the Student's T test, while categorical data were studied using χ 2 or Fisher exact test. Survival curves were estimated using the Kaplan-Meier method, and the log-rank test was used to compute differences between the curves. Statistical significance was set at P < 0.05.
Written informed consent was taken from all patients and study protocols were approved by the institutional review board at the faculty of medicine, Zagazig University. Progression free and overall survival were significantly higher in patients with low MACC-1 expression compared to patients with high expression (Log Rank test, p = 0.02 and 0.04, consequently) (Figure 2 ).
Results

MACC
Discussion
In Egypt, gastric cancer is the 12 th most common cancer in both sexes representing 1.6% of the total cancers. It is the 12 th leading cause of cancer death representing 2.2% of the total cancer mortality. The median age of GC in the Egyptians is 56
years. The incidence rises with age and 55% of cases occur between 50 and 70 years of age [19] .
A number of studies have shown that gastric cancer progression, invasion and metastasis are associated with distinct gene expression profiles [1] [20] . In order to identify genes differentially expressed in gastric cancer, gene expression in gastric cancer specimens and healthy tissues were profiled using microarrays.
Four hundred thirty-four genes were identified of which, 169 expressed sequence tags (ESTs) that were up-regulated at least 2 folds in primary gastric carcinomas and of these, MACC-1 was found to be one of the most highly upregulated genes [19] [20] . In our study, we verified this microarray data by immune-histo-chemical analysis. We found that gastric cancer specimens expressed high levels of MACC-1, 
Conclusion
Our study found that MACC-1 expression is strongly related to gastric cancer stage and both progression free and overall survival, suggesting that MACC-1 promote tumorigenesis and its expression may be used as signal of bad prognosis in gastric cancer.
Limitation of the study includes limited patient number and lack of long term follow up that could be solved in future studies in order to increase the accuracy of statistics and add another dimension to MACC-1 as prognostic marker.
